Sharekhan

Entero Healthcare Solutions Ltd

Mon 1/12/2025,10:19:54 | NSE : ENTERO

₹ 1057.40-5.30 (-0.50%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1060.00

Previous Close

₹ 1062.70

Volume

22902

Mkt Cap ( Rs. Cr)

₹4600.85

High

₹ 1067.80

Low

₹ 1045.20

52 Week High

₹ 1563.90

52 Week Low

₹ 1022.00

Book Value Per Share

₹ 386.76

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

41%

Sell Order Quantity

59%

Bid Price

Qty

1055.80

10

1056.00

11

1056.00

1

1056.00

3

1055.00

13

Bid Total

19590

Bid Price

Qty

1056.80

18

1057.00

20

1057.00

4

1057.00

18

1057.00

20

Bid Total

27675

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Nov 2025, 6:08PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Nov 2025, 6:01PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on December 02, 2025 at 09:00 AM (IST)
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    20 Nov 2025, 5:40PM Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Transcript of Earnings call
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Nov 2025, 5:40PM Entero Healthcare Solutions Limited has informed the Exchange about Transcript
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    17 Nov 2025, 4:12PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on November 21, 2025 at 10:00 AM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Nov 2025, 4:12PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Copy of Newspaper Publication

    14 Nov 2025, 11:10AM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication for unaudited Financial Results for the quarter and
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Nov 2025, 6:15PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Recording of Earnings Call/ Conferenc
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Nov 2025, 6:15PM Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording
  • Entero Healthcare So - Investor Presentation

    12 Nov 2025, 9:56PM Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 Nov 2025, 9:56PM Investor Presentation on Unaudited Financial Results for the Quarter and Half year ended September 30, 2025
  • Entero Healthcare So Q2 net profit down 62.82% at Rs 5.70 cr

    12 Nov 2025, 7:33PM The company reported standalone net profit of Rs 5.70 crore for the quarter ended September 30, 2025 as compared to Rs 15.33 crore in the same period
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Acquisition

    12 Nov 2025, 7:24PM Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition
  • Entero Healthcare So - Acquisition

    12 Nov 2025, 7:24PM Entero Healthcare Solutions Limited has informed the Exchange about Acquisition
  • Entero Healthcare So - Change in Management

    12 Nov 2025, 7:19PM Entero Healthcare Solutions Limited has informed the Exchange about change in Designation of Mr. Abhitesh Kumar from President Retail Business & New
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Change in Management

    12 Nov 2025, 7:19PM Change in designation of Mr. Abhitesh Kumar from President- Retail Business and New Initiatives to Chief Growth Officer of the Company
  • Entero Healthcare So - Monitoring Agency Report

    12 Nov 2025, 7:15PM Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended September 30, 2025.
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    12 Nov 2025, 7:15PM Submission of Monitoring Agency Report for the Quarter ended September 30, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    12 Nov 2025, 7:07PM Allotment of Equity Shares pursuant to exercise of ESOP under Employee Stock Option Scheme 2023
  • Entero Healthcare So - Allotment of Securities

    12 Nov 2025, 7:07PM Entero Healthcare Solutions Limited has informed the Exchange regarding allotment of 2030 securities pursuant to ESOP/ESPS at its meeting held on Nove
  • Entero Healthcare So - Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025

    12 Nov 2025, 7:02PM Submission o Unaudited Financial Results for the quarter and half year ended September 30, 2025
  • Entero Healthcare So - Outcome of Board Meeting

    12 Nov 2025, 7:02PM Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
  • Entero Healthcare So - Outcome of Board Meeting

    12 Nov 2025, 6:51PM Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on November 12, 2025.
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Dated November 12, 2025

    12 Nov 2025, 6:51PM Outcome of Board Meeting dated November 12, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    7 Nov 2025, 6:05PM Intimation of Earnings call on unaudited Financial Results of the Company for the Quarter and half year ended September 30, 2025
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Nov 2025, 6:05PM Entero Healthcare Solutions Limited has informed the Exchange about Earning calls on unaudited Financial Results of the Company for the quarter and ha
  • Entero Healthcare So - Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended September 30, 202

    29 Oct 2025, 11:24AM Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to c
  • Entero Healthcare So has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    17 Oct 2025, 8:00PM As of September 2025, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Oct 2025, 5:25PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on October 14, 2025 at 04:30 PM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Oct 2025, 5:25PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2025, 5:15PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025
  • Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Oct 2025, 5:15PM Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Oct 2025, 5:36PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on October 09, 2025 at 11:00 AM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Oct 2025, 5:36PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Sale or disposal

    29 Sep 2025, 1:28PM Entero Healthcare Solutions Limited has informed the Exchange about Sale of subsidiary.
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Acquisition

    29 Sep 2025, 1:28PM Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition
  • Entero Healthcare So - Acquisition

    29 Sep 2025, 1:28PM Entero Healthcare Solutions Limited has informed the Exchange about Acquisition.
  • Entero Healthcare So - Outcome of Board Meeting

    29 Sep 2025, 1:24PM Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on September 29, 2025.
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting

    29 Sep 2025, 1:24PM Outcome of Board meeting dated September 29, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

    29 Sep 2025, 1:33PM Sale of entire stake (100%) in Suprabhat Pharmaceutical Private Limited, a wholly-owned subsidiary of the Company
  • Entero Healthcare So - Trading Window

    25 Sep 2025, 5:50PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Sep 2025, 7:11PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on September 24, 2025 at 10:00 AM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Sep 2025, 7:10PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Sep 2025, 7:23PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on September 23, 2025 at 09:00 AM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Sep 2025, 7:23PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Appointment

    18 Sep 2025, 7:19PM Entero Healthcare Solutions Limited has informed the Exchange regarding Appointment of M/s. BNP and Associates, Practicing Company Secretaries as Se
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Change in Management

    18 Sep 2025, 7:19PM Appointment of M/s. BNP & Associates, Practicing Company Secretaries as Secretarial Auditor of the Company
  • Entero Healthcare So - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    18 Sep 2025, 7:02PM Submission of consolidated report issued by Scrutinizer for 7th AGM held on September 18, 2025
  • Entero Healthcare So - Shareholder Meeting / Postal Ballot-Outcome of AGM

    18 Sep 2025, 6:51PM Summary of proceedings of 7th Annual General Meeting of the Company for the FY 2024-25 held on Thursday, September 18, 2025 along with Voting Results
  • Entero Healthcare So - Shareholders meeting

    18 Sep 2025, 6:46PM Entero Healthcare Solutions Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 18, 2025. Further, the
  • Entero Healthcare So - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    18 Sep 2025, 7:02PM Submission of consolidated report issued by Scrutinizer for 7th AGM held on September 18, 2025
  • Entero Healthcare So - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    18 Sep 2025, 7:02PM Submission of consolidated report issued by Scrutinizer for 7th AGM held on September 18, 2025
  • Entero Healthcare So - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    18 Sep 2025, 7:02PM Submission of consolidated report issued by Scrutinizer for 7th AGM held on September 18, 2025
  • Entero Healthcare So - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    18 Sep 2025, 7:02PM Submission of consolidated report issued by Scrutinizer for 7th AGM held on September 18, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Sep 2025, 6:34PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on September 16, 2025 at 09:00 AM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Sep 2025, 6:30PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address

    3 Sep 2025, 5:23PM Change in Address of Corporate Office- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Entero Healthcare So - Address Change

    3 Sep 2025, 5:23PM Entero Healthcare Solutions Limited has informed the Exchange regarding change in Corporate Office of the company.

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1650.38 1626.414 675.232 581.205 486.4381
Liabilities 1650.38 1626.414 675.232 581.205 486.4381
Equity 43.508 43.494 4.112 3.85 0.1002
Gross Profit -30.346 -34.494 -43.916 -53.716 -36.9478
Net Profit 19.181 38.44 -12.455 -40.847 -18.1512
Cash From Operating Activities -109.016 -75.65 -56.909 -44.698 -68.1958
NPM(%) 4.69 12.08 -7 -29.75 -18.17
Revenue 408.67 318.161 177.69 137.286 99.8955
Expenses 439.016 352.655 221.606 191.002 136.8433
ROE(%) 1.13 2.28 -0.74 -2.42 -1.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 795.10 0.28 0.00 590.18 301.39 0.63
Lotus Eye Hospital and Institute Ltd 105.10 -0.52 328.44 2150.55 3.55 0.00
Vaishali Pharma Ltd 8.80 0.11 0.00 13491.09 3.13 0.00
Astec Lifesciences Ltd 824.00 -1.66 0.00 2028.01 -604.77 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Read More

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

The current price of Entero Healthcare Solutions Ltd is ₹ 1057.40.

The 52-week high for Entero Healthcare Solutions Ltd is ₹ 1067.80 and the 52-week low is ₹ 1045.20.

The market capitalization of Entero Healthcare Solutions Ltd is currently ₹ 4600.85. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Entero Healthcare Solutions Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Entero Healthcare Solutions Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Entero Healthcare Solutions Ltd shares.

The CEO of Entero Healthcare Solutions Ltd is Mr.Prabhat Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT